Activation_NN
of_IN
E2F-mediated_JJ
transcription_NN
by_IN
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
Tax_NN
protein_NN
in_IN
a_DT
p16_NN
-LRB-_-LRB-
INK4A_NN
-RRB-_-RRB-
-_:
negative_JJ
T-cell_NN
line_NN
._.

The_DT
human_JJ
T-cell_NN
leukemia_NN
virus_NN
type_NN
I_CD
-LRB-_-LRB-
HTLV-I_NN
-RRB-_-RRB-
is_VBZ
a_DT
causative_JJ
agent_NN
of_IN
adult_JJ
T-cell_NN
leukemia_NN
._.

Although_IN
the_DT
exact_JJ
mechanism_NN
by_IN
which_WDT
HTLV-I_NN
contributes_VBZ
to_TO
leukemogenesis_NN
is_VBZ
still_RB
unclear_JJ
,_,
the_DT
Tax_NN
protein_NN
is_VBZ
thought_VBN
to_TO
play_VB
a_DT
major_JJ
role_NN
in_IN
this_DT
process_NN
._.

This_DT
40-kDa_JJ
polypeptide_NN
is_VBZ
able_JJ
to_TO
interact_VB
with_IN
the_DT
tumor_NN
suppressor_NN
p16_NN
-LRB-_-LRB-
INK4A_NN
-RRB-_-RRB-
._.

Consequently_RB
,_,
Tax_NN
can_MD
activate_VB
the_DT
signaling_NN
pathway_NN
that_WDT
lead_VBP
to_TO
the_DT
release_NN
of_IN
E2F_NN
that_WDT
in_IN
turn_NN
induces_VBZ
expression_NN
of_IN
factors_NNS
required_VBN
for_IN
cell_NN
cycle_NN
progression_NN
._.

In_IN
this_DT
paper_NN
,_,
we_PRP
demonstrate_VBP
that_IN
Tax_NN
can_MD
also_RB
activate_VB
E2F-mediated_JJ
transcription_NN
independently_RB
of_IN
p16_NN
-LRB-_-LRB-
INK4A_NN
-RRB-_-RRB-
._.

Indeed_RB
,_,
when_WRB
Tax_NN
is_VBZ
coexpressed_VBN
with_IN
the_DT
E2F-1_NN
transcription_NN
factor_NN
in_IN
CEM_NN
T-cells_NNS
,_,
which_WDT
lack_VBP
expression_NN
of_IN
p16_NN
-LRB-_-LRB-
INK4A_NN
-RRB-_-RRB-
,_,
it_PRP
strongly_RB
potentiates_VBZ
the_DT
E2F-dependent_JJ
activation_NN
of_IN
a_DT
reporter_NN
construct_NN
driven_VBN
by_IN
a_DT
promoter_NN
containing_VBG
E2F_NN
binding_NN
sites_NNS
._.

This_DT
stimulation_NN
is_VBZ
abrogated_VBN
by_IN
mutations_NNS
affecting_VBG
the_DT
E2F-binding_JJ
sites_NNS
._.

In_IN
addition_NN
,_,
Tax_NN
also_RB
stimulates_VBZ
the_DT
transcription_NN
of_IN
the_DT
E2F-1_NN
gene_NN
itself_NN
._.

Using_VBG
Tax_NN
mutants_NNS
that_WDT
fail_VBP
to_TO
activate_VB
either_CC
ATF_NN
-_:
or_CC
NF-kappaB-dependent_JJ
promoters_NNS
and_CC
different_JJ
5_CD
'_POS
truncation_NN
mutants_NNS
of_IN
the_DT
E2F-1_NN
promoter_NN
,_,
we_PRP
show_VBP
that_IN
the_DT
Tax-dependent_JJ
transcriptional_JJ
control_NN
of_IN
the_DT
E2F1_NN
gene_NN
involves_VBZ
,_,
at_IN
least_JJS
in_IN
part_NN
,_,
the_DT
ATF_NN
binding_NN
site_NN
located_JJ
in_IN
the_DT
E2F-1_NN
promoter_NN
._.

